GPCR (structuretx.com) Bozor qiymatining balans qiymatiga nisbati

Structure Therapeutics Inc (GPCR) kompaniyasining rasmiy ramzlari

Structure Therapeutics (GPCR) formula ishlab chiqish va sinovlarini tashqi pudratchilarga topshirish orqali kapital xarajatlarini minimallashtiradi. O'zining noyob oral yechimlari tufayli, startap narxlar urushlaridan qochgan holda, vazn yo'qotish segmentida muhim nishani egallashga intilmoqda. Daromadlar innovatsion diabetga qarshi tabletkalarning bozorga chiqarilishiga asoslangan bo'lib, u yerda ko'rsatkich 1.10 darajasida turibdi. Baholash vositasi bo'lib xizmat qiluvchi ushbu narxlar grafigi ushbu aktivning dinamikasini aniq vizuallashtiradi.

GPCR Structure Corp: Balans qiymatiga nisbatan bozor qiymati 28.04.2023 - 27.10.2026 oraligʻida

Structure Therapeutics Inc (GPCR) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Structure Therapeutics|GPCR - Adolatli qiymat konsensusi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Structure Pharma|GPCR - Biznesning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Structure Therapeutics|GPCR - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati structuretx.com|GPCR - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Structure Therapeutics|GPCR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Structure Pharma|GPCR - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Structure Pharma
Kompaniyaning dastlabki tahlili:Structure Therapeutics - GPCR
Structure Pharma original mahsuloti

Ushbu koeffitsiyent sof aktivlardan yuqori bo'lgan bozor qiymati mukofotini belgilab, balans hisobotining ob'ektiv qiymatini investorlarning sub'ektiv kutganlaridan ajratadi. Structure Therapeutics (GPCR) kompaniyasining bozor bahosi va uning balans qiymati o'rtasidagi bog'liqlikni tahlil qilish orqali, Structure Therapeutics (GPCR) kompaniyasining yuqori baholanishi joriy resurslar bilan emas, balki pul oqimining past bashorat qilinuvchanligi sharoitida metabolik dori vositalarini ishlab chiqishda kelgusidagi klinik muvaffaqiyatlar potentsiali bilan bog'liqligi ayon bo'ladi.

Asosiy raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Ascendis Pharma A/S ASND|MDGL (madrigalpharma.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Corcept Therapeutics Incorporated CORT|Sof aktivlarga nisbatan bozor kapitallashuvi Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Metsera Therapeutics (MTSR)|Bozor kapitallashuvining balans qiymatiga nisbati MLTX (MoonLake Immunotherapeutics)|crinetics.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Balans qiymatiga nisbatan bozor qiymati|FOLD (Amicus Pharma) - Bozor qiymatining balans qiymatiga nisbati|89bio Pharma (ETNB) - Kapitallashuvning sof aktivlarga nisbati|AGIO (Agios Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati mimedx.com (MDXG)|Rezolute (RZLT) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|sagimet.com (SGMT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|BIOA - Kapitallashuvning sof aktivlarga nisbati|Biomea Fusion Inc (BMEA) - Bozor kapitallashuvining balans qiymatiga multiplikatori|QNCX (Quince Therapeutics Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Fractyl Health, Inc|Bozor kapitallashuvining balans qiymatiga nisbati vTv Therapeutics Inc. (VTVT)|Bozor qiymatining balans qiymatiga nisbati ATPC (agapeatpgroup.com)|PLUR: Bozor qiymatining balans qiymatiga nisbati|Synlogic Inc. - Bozor qiymatining balans qiymatiga koeffitsiyenti|LPCN - Bozor qiymatining balans qiymatiga nisbati|MTNB - Bozor qiymatining balans qiymatiga nisbati|Spruce Biosciences - Bozor kapitallashuvining balans qiymatiga nisbati|GLTO (galecto.com) - Balans qiymatiga nisbatan bozor kapitallashuvi|CTCX: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi LUMO|Bozor qiymatining balans qiymatiga nisbati ONVO (Organovo Holdings Inc)|Kapitallashuvning sof aktivlarga nisbati RDUS (Radius Pharmaceuticals)